Old Web
English
Sign In
Acemap
>
authorDetail
>
Frede Donskov
Frede Donskov
Aarhus University
Pathology
Medicine
Oncology
Nivolumab
Cancer
2
Papers
152
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
3LBA CheckMate 025: a randomized, open-label, phase III study of nivolumab (NIVO) versus everolimus (EVE) in advanced renal cell carcinoma (RCC)
2015
European Journal of Cancer
Padmanee Sharma
Bernard Escudier
David F. McDermott
Saby George
Hans J. Hammers
S. Srinivas
Scott S. Tykodi
Jeffrey A. Sosman
Giuseppe Procopio
Elizabeth R. Plimack
Daniel Castellano
Howard Gurney
Frede Donskov
Petri Bono
John Wagstaff
Thomas Gauler
Takeshi Ueda
Li An Xu
Ian M. Waxman
Robert J. Motzer
Show All
Source
Cite
Save
Citations (4)
Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the International mRCC Database Consortium criteria
2013
Cancer
Nils Kroeger
Wanling Xie
Jae Lyn Lee
Georg A. Bjarnason
Jennifer J. Knox
Mary J. MacKenzie
Lori Wood
Sandy Srinivas
Ulka N. Vaishamayan
Sun Young Rha
Sumanta K. Pal
Takeshi Yuasa
Frede Donskov
Neeraj Agarwal
Christian Kollmannsberger
Min Han Tan
Scott North
Brian I. Rini
Toni K. Choueiri
Daniel Y. C. Heng
Show All
Source
Cite
Save
Citations (148)
1